| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/04/2001 | CA2593287A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | CA2587112A1 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 01/04/2001 | CA2583703A1 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 01/04/2001 | CA2380873A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | CA2376914A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | CA2372700A1 Diagnostic test for thrombotic or thromboembolic disease |
| 01/04/2001 | CA2370517A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | CA2339404A1 Synthetic peptide immunogens and antibodies thereto |
| 01/03/2001 | EP1064951A2 Erythropoietin derivatives |
| 01/03/2001 | EP1064389A1 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use |
| 01/03/2001 | EP1064382A2 Polypeptides homologous to vegf and bmp1 |
| 01/03/2001 | EP1064376A2 GFR$g(a)3 AND ITS USES |
| 01/03/2001 | EP0816506B1 System for the expression of heterologous antigens as fusion proteins |
| 01/03/2001 | CN1060216C Improved methods for the preparation of endotoxinbinding proteins |
| 01/02/2001 | US6169175 Dna sequence encoding a variant m2 polypeptide of influenza a having a deletion of a domain, thus causing a reduction in hydrophobicity and an increase solubility in aqueous buffers |
| 01/02/2001 | US6168926 Screening for modulators of preferential enzyme activity; incubating cells with modulators and detecting expression of reporter molecules, amplification of expression indicates an inhibitor, decreased expression indicates an activator |
| 01/02/2001 | US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv |
| 01/02/2001 | US6168783 Antagonists of interleukin-15 |
| 12/28/2000 | WO2000078947A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
| 12/28/2000 | WO2000037640A3 Compositions and methods for the treatment of tumor |
| 12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
| 12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2000 | WO2000030667A3 Compositions and methods using lactadherin or variants thereof |
| 12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
| 12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
| 12/28/2000 | CA2375480A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/27/2000 | EP1062348A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase |
| 12/27/2000 | EP1062344A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 12/27/2000 | EP1062332A2 Human receptor proteins; related reagents and methods |
| 12/27/2000 | EP1062224A1 Modified factor viii |
| 12/27/2000 | EP0791065B1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 12/27/2000 | CN1278300A Multivalent antigen-binding proteins |
| 12/27/2000 | CN1278183A Soluble MHC complexes and methods of use thereof |
| 12/26/2000 | US6166192 PGC-1, a novel brown fat PPARγ coactivator |
| 12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
| 12/26/2000 | US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents |
| 12/26/2000 | US6165738 Hybrid of two human isoforms; for recombinant production; for diagnosis, presymptomatic detection, and prevention of insulin dependent diabetes mellitus |
| 12/26/2000 | US6165730 Amino acid sequences of epitopes; for immunoassay diagnosis and immunogens for vaccines |
| 12/26/2000 | US6165476 Fusion proteins with an immunoglobulin hinge region linker |
| 12/26/2000 | US6165470 Hybrid macromolecules composed of albumin derivatives coupled to derivatives of the cd4 receptor having a normal or a higher affinity for the hiv-1 virus. |
| 12/26/2000 | US6165466 Antagonists of interleukin-15 |
| 12/26/2000 | US6165464 Monoclonal antibodies directed to the HER2 receptor |
| 12/21/2000 | WO2000077210A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 12/21/2000 | WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 12/21/2000 | WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/21/2000 | WO2000076308A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 12/21/2000 | WO2000046240A3 Polypeptides involved in immune response |
| 12/21/2000 | CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 12/21/2000 | CA2373628A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 12/20/2000 | EP1060261A1 Poly zinc finger proteins with improved linkers |
| 12/20/2000 | EP1060194A1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 12/19/2000 | US6162900 Amino acid sequences of polypeptide which transports cadmium, iron(ii), cobalt, manganese, lead, mercury, and zinc; transgenic plants with increased metal uptake for use as nutrient supplements or removing toxic metals from soils |
| 12/19/2000 | CA2053206C Monoclonal antibodies against melanoma |
| 12/14/2000 | WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof |
| 12/14/2000 | WO2000075347A2 Tet repressor-based transcriptional regulatory proteins |
| 12/14/2000 | WO2000075346A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
| 12/14/2000 | WO2000075339A1 Substrate trapping protein tyrosine phosphatases |
| 12/14/2000 | WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof |
| 12/14/2000 | WO2000075332A2 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS |
| 12/14/2000 | WO2000075329A1 Targeted angiogenesis |
| 12/14/2000 | WO2000075323A1 Tek antagonists |
| 12/14/2000 | WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 12/14/2000 | WO2000075317A2 Compositions and methods for the treatment of tumor |
| 12/14/2000 | WO2000075187A1 An integrin heterodimer and an alpha subunit thereof |
| 12/14/2000 | WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 12/14/2000 | WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 12/14/2000 | WO2000049040A3 Antimicrobial/endotoxin neutralizing polypeptide |
| 12/14/2000 | WO2000049039A3 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 12/14/2000 | CA2504679A1 Compositions and methods for the treatment of tumor |
| 12/14/2000 | CA2501815A1 Compositions and methods for the treatment of tumor |
| 12/14/2000 | CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins |
| 12/14/2000 | CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof |
| 12/14/2000 | CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 12/14/2000 | CA2376062A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
| 12/14/2000 | CA2376058A1 Use of the regulatory subunit of the camp dependent protein kinase (pka) from dictyostelium for camp measurements |
| 12/14/2000 | CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 12/14/2000 | CA2375876A1 An integrin heterodimer and an alpha subunit thereof |
| 12/14/2000 | CA2375617A1 Targeted angiogenesis |
| 12/14/2000 | CA2375145A1 Substrate trapping protein tyrosine phosphatases |
| 12/14/2000 | CA2374851A1 Tek antagonists |
| 12/14/2000 | CA2371434A1 Compositions and methods for the treatment of tumor |
| 12/13/2000 | EP1059533A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 12/13/2000 | EP1058731A2 Production of mycobacterial polypeptides by lactic acid bacteria |
| 12/13/2000 | CN1276833A Vaccine |
| 12/13/2000 | CN1276797A Low-toxicity human interferon-alpha analog |
| 12/13/2000 | CN1276796A Biomolecules comprising elastomeric peptide |
| 12/12/2000 | US6159705 Screening by using yeast cell which expresses a heterologous receptor which is functionally integrated into an endogenous yeast signaling pathway, contacting with a test compound, and detecting alteration in signal |
| 12/07/2000 | WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 12/07/2000 | WO2000073500A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS |
| 12/07/2000 | WO2000073459A1 Four-helical bundle protein zsig81 |
| 12/07/2000 | WO2000073458A1 Secreted alpha-helical protein-31 |
| 12/07/2000 | WO2000073453A1 T-bet compositions and methods of use thereof |
| 12/07/2000 | WO2000073451A1 Mammalian receptor proteins; related reagents and methods |
| 12/07/2000 | WO2000073448A1 Adipocyte complement related protein homolog zacrp7 |
| 12/07/2000 | WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3) |
| 12/07/2000 | WO2000073444A1 Adipocyte complement related protein homolog zacrp5 |
| 12/07/2000 | WO2000073437A1 Assays for caspase activity using green fluorescent proteins |
| 12/07/2000 | WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth |
| 12/07/2000 | WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors |